HUE045889T2 - Használatkész ketorolak készítmények - Google Patents

Használatkész ketorolak készítmények

Info

Publication number
HUE045889T2
HUE045889T2 HUE11835216A HUE11835216A HUE045889T2 HU E045889 T2 HUE045889 T2 HU E045889T2 HU E11835216 A HUE11835216 A HU E11835216A HU E11835216 A HUE11835216 A HU E11835216A HU E045889 T2 HUE045889 T2 HU E045889T2
Authority
HU
Hungary
Prior art keywords
ready
ketorolac formulations
use ketorolac
formulations
ketorolac
Prior art date
Application number
HUE11835216A
Other languages
English (en)
Inventor
Joseph Pergolizzi
Alexander Mironov
Chad Pickens
Douglas Johnson
Original Assignee
Rtu Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rtu Pharmaceuticals Llc filed Critical Rtu Pharmaceuticals Llc
Publication of HUE045889T2 publication Critical patent/HUE045889T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE11835216A 2010-10-21 2011-10-21 Használatkész ketorolak készítmények HUE045889T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40538410P 2010-10-21 2010-10-21
US201161481602P 2011-05-02 2011-05-02

Publications (1)

Publication Number Publication Date
HUE045889T2 true HUE045889T2 (hu) 2020-01-28

Family

ID=45973506

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE11835216A HUE045889T2 (hu) 2010-10-21 2011-10-21 Használatkész ketorolak készítmények

Country Status (18)

Country Link
US (5) US9421191B2 (hu)
EP (3) EP2616064B1 (hu)
JP (1) JP6013346B2 (hu)
KR (4) KR102307601B1 (hu)
CN (2) CN103167800A (hu)
CA (1) CA2814805C (hu)
CY (1) CY1122516T1 (hu)
DK (1) DK2616064T3 (hu)
ES (2) ES2753981T3 (hu)
HR (1) HRP20191994T1 (hu)
HU (1) HUE045889T2 (hu)
LT (1) LT2616064T (hu)
MX (1) MX346879B (hu)
PL (1) PL2616064T3 (hu)
PT (1) PT2616064T (hu)
RS (1) RS59526B1 (hu)
SI (1) SI2616064T1 (hu)
WO (1) WO2012054831A2 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2616064T1 (sl) 2010-10-21 2019-12-31 Rtu Pharmaceuticals Llc Pripravki ketorolaka, pripravljeni za uporabo
US10098872B1 (en) 2013-07-22 2018-10-16 William Bradley Worthington Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992485B2 (en) 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11559521B2 (en) * 2013-07-22 2023-01-24 William Bradley Worthington Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992484B2 (en) 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CN103830171B (zh) * 2014-03-04 2015-11-18 鲁南制药集团股份有限公司 一种酮咯酸氨丁三醇注射液及其制备方法
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
PL3256138T3 (pl) * 2015-11-25 2022-08-01 Axsome Therapeutics, Inc. Kompozycje farmaceutyczne zawierające meloksykam
IT201600075246A1 (it) * 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
CN110612103B (zh) * 2017-05-10 2023-08-22 艾克萨姆治疗公司 包含美洛昔康的药物组合物
FR3101917B1 (fr) 2019-10-09 2022-07-15 Ifp Energies Now Système de refroidissement à radiateur unique
CN110812325B (zh) * 2019-11-13 2022-04-05 鲁南制药集团股份有限公司 一种提高酮咯酸氨丁三醇注射液存储稳定性的方法
CN113679676A (zh) * 2020-05-19 2021-11-23 南京海融医药科技股份有限公司 一种左酮咯酸的药物组合物及其制备方法
CN114159384B (zh) * 2021-02-07 2023-04-07 南京锐志生物医药有限公司 一种化学性质稳定的低刺激性酮咯酸氨丁三醇注射液
EP4360622A1 (en) * 2021-06-24 2024-05-01 Shanghai Aurora Biotechnology Co., Ltd. Ketorolac liquid composition, preparation method therefor, and application thereof
CN113384524A (zh) * 2021-07-05 2021-09-14 四川尚锐生物医药有限公司 一种稳定的酮咯酸氨丁三醇注射液的制备方法
CN114191384A (zh) * 2021-12-20 2022-03-18 成都倍特药业股份有限公司 一种即用型酮咯酸氨丁三醇和氢溴酸依他佐辛组合液体制剂
CN114432240A (zh) * 2022-03-04 2022-05-06 郑州市中心医院 一种稳定不刺激的酮咯酸氨丁三醇注射液及其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US5214052A (en) 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
CA2265767C (en) 1997-07-11 2007-12-04 Nobuyuki Hanamura Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
DK1165044T3 (da) 1999-03-26 2004-10-25 Pozen Inc Höjpotente dihydroergotaminsammensætninger
US20040022787A1 (en) 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
US6509027B2 (en) * 2001-02-12 2003-01-21 Supergen, Inc. Injectable pharmaceutical composition comprising coated particles of camptothecin
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
PT2368553E (pt) 2003-04-08 2015-03-03 Progenics Pharm Inc Formulações farmacêuticas contendo metilnaltrexona
US20070049552A1 (en) 2003-04-14 2007-03-01 Babu Manoj M Fluoroquinolone formulations and methods of making and using the same
US20080317681A1 (en) * 2003-07-11 2008-12-25 Petros Gebreselassie Compositions containing a stain removing complex, and methods of making and using the same
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
CA2584184A1 (en) * 2004-10-15 2006-04-27 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
CA2617920C (en) 2005-09-01 2014-05-27 Baxter International Inc. Argatroban formulation comprising an acid as solubilizer
US20070142478A1 (en) 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US8492400B2 (en) 2006-02-09 2013-07-23 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
DOP2007000055A (es) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
KR20090040258A (ko) 2006-04-18 2009-04-23 이케이알 테라퓨틱스, 인코포레이티드 사전혼합된, 즉석용 약제 조성물
WO2007146795A2 (en) 2006-06-12 2007-12-21 Ironwood Pharmaceuticals, Inc. Pharmaceutical formulation for parenteral administration
JP2009542665A (ja) * 2006-06-29 2009-12-03 シェーリング コーポレイション 糖を含まない保存に安定な抗ヒスタミンシロップ
US20080014274A1 (en) 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US20080057023A1 (en) 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
EP2083823A4 (en) 2006-09-27 2010-01-13 Eagle Pharmaceuticals Inc ALCOHOL-FREE FORMULATION OF ARGATROBAN
KR100836624B1 (ko) 2006-12-08 2008-06-10 한국전자통신연구원 가변 고속 푸리에 변환 장치 및 그 방법
US20080312154A1 (en) * 2007-06-15 2008-12-18 Barbara Lee Peterlin Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin
EP2197429B9 (en) 2007-09-03 2016-10-26 Nanotherapeutics, Inc. Particulate compositions for delivery of poorly soluble drugs
WO2009087658A2 (en) 2007-11-07 2009-07-16 Sun Pharma Advanced Research Company Limited Composition suitable for parenteral administration
CA2705733C (en) 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
US20090239836A1 (en) * 2008-03-24 2009-09-24 Mary Lee Ciolkowski Multifunctional Ophthalmic Compositions
US8956636B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprosing ketorolac
US7635773B2 (en) * 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
TWI397038B (zh) * 2008-11-05 2013-05-21 Au Optronics Corp 使用半源極驅動架構之顯示面板及其顯示資料供應方法
KR20180123176A (ko) * 2010-07-19 2018-11-14 바이오젠 체사피크 엘엘씨 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
EP2596112A4 (en) 2010-07-21 2015-01-21 Cumberland Pharmaceuticals Inc ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR
SI2616064T1 (sl) 2010-10-21 2019-12-31 Rtu Pharmaceuticals Llc Pripravki ketorolaka, pripravljeni za uporabo

Also Published As

Publication number Publication date
CN108703948A (zh) 2018-10-26
EP3632432A1 (en) 2020-04-08
JP6013346B2 (ja) 2016-10-25
EP3632432B1 (en) 2022-09-14
CA2814805A1 (en) 2012-04-26
LT2616064T (lt) 2019-11-25
EP4190327A1 (en) 2023-06-07
US20170007575A1 (en) 2017-01-12
US20190105301A1 (en) 2019-04-11
KR102307601B1 (ko) 2021-09-30
WO2012054831A2 (en) 2012-04-26
KR20200078541A (ko) 2020-07-01
US9962371B2 (en) 2018-05-08
KR102114568B1 (ko) 2020-05-22
US20180280351A1 (en) 2018-10-04
DK2616064T3 (da) 2019-11-11
PL2616064T3 (pl) 2020-02-28
KR20180119610A (ko) 2018-11-02
CA2814805C (en) 2021-11-02
RS59526B1 (sr) 2019-12-31
CY1122516T1 (el) 2021-01-27
ES2753981T3 (es) 2020-04-15
ES2933198T3 (es) 2023-02-02
US10278959B2 (en) 2019-05-07
US20120101142A1 (en) 2012-04-26
KR20190085561A (ko) 2019-07-18
KR20140012029A (ko) 2014-01-29
SI2616064T1 (sl) 2019-12-31
EP2616064A4 (en) 2016-07-20
MX2013004393A (es) 2014-09-12
US20220023260A1 (en) 2022-01-27
JP2013543843A (ja) 2013-12-09
US9421191B2 (en) 2016-08-23
MX346879B (es) 2017-04-03
PT2616064T (pt) 2019-11-06
EP2616064A2 (en) 2013-07-24
US11116750B2 (en) 2021-09-14
CN103167800A (zh) 2013-06-19
WO2012054831A3 (en) 2012-06-07
EP2616064B1 (en) 2019-08-07
HRP20191994T1 (hr) 2020-02-07

Similar Documents

Publication Publication Date Title
HUE045889T2 (hu) Használatkész ketorolak készítmények
GB201010193D0 (en) Medicinal use
GB201015271D0 (en) Improvements relating to wheelchairs
AU332760S (en) Spatula head
IL222637A0 (en) Alcohol-resistant formulations
EP2620160A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
EP2623092A4 (en) COSMETIC COMPOSITION
GB201003218D0 (en) Improvements relating to platform devices
GB201019441D0 (en) Improvements to hand irons
ZA201300194B (en) Formulations
PL2407155T3 (pl) Formulacje inekalcytolu
GB201110193D0 (en) Formulations
GB201018816D0 (en) Improvements in or relating to plugs
GB201013513D0 (en) Formulations
EP2536693A4 (en) SUBSTITUTED 2-IMIDAZOLIDONES AND THE LIKE
GB201004616D0 (en) Improvements relating to dispensers
ZA201300196B (en) Formulations
GB201018584D0 (en) Improvements in or relating to stairlifts
AU2010100004A4 (en) Ready to serve oysters
GB201011738D0 (en) Further improvements to chair arrangement
GB201018649D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201012589D0 (en) Formulations